• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门腔分流大鼠的血浆氧化还原状态受损——抗氧化能力降低的风险。

Plasma redox status is impaired in the portacaval shunted rat--the risk of the reduced antioxidant ability.

作者信息

Aller Maria-Angeles, García-Fernández Maria-Inmaculada, Sánchez-Patán Fernando, Santín Luis, Rioja José, Anchuelo Raquel, Arias Jaime, Arias Jorge-Luis

机构信息

Surgery I Department, School of Medicine, Complutense University of Madrid, Spain.

出版信息

Comp Hepatol. 2008 Feb 5;7:1. doi: 10.1186/1476-5926-7-1.

DOI:10.1186/1476-5926-7-1
PMID:18251997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2262055/
Abstract

BACKGROUND

Portacaval shunting in rats produces a reduction of hepatic oxidant scavenging ability. Since this imbalance in hepatic oxidant/antioxidant homeostasis could coexist with systemic changes of oxidant stress/antioxidant status, plasma oxidants and antioxidant redox status in plasma of portacaval shunted-rats were determined.

RESULTS

Male Wistar male: Control (n = 11) and with portacaval shunt (PCS; n = 11) were used. Plasma levels of the oxidant serum advanced oxidation protein products (AOPP), lipid hydroperoxides (LOOH), the antioxidant total thiol (GSH) and total antioxidant status (TAX) were measured. Albumin, ammonia, Aspartate-aminotransferase (AST), Alanine-aminotransferase (ALT), thiostatin and alpha-1-acid glycoprotein (alpha1-AGP) were also assayed 4 weeks after the operation. AOPPs were significantly higher (50.51 +/- 17.87 vs. 36.25 +/- 7.21 microM; p = 0.02) and TAX was significantly lower (0.65 +/- 0.03 vs. 0.73 +/- 0.06 mM; p = 0.007) in PCS compared to control rats. Also, there was hypoalbuminemia (2.54 +/- 0.08 vs. 2.89 +/- 0.18 g/dl; p = 0.0001) and hyperammonemia (274.00 +/- 92.25 vs. 104.00 +/- 48.05 microM; p = 0.0001) and an increase of thiostatin (0.23 +/- 0.04 vs. 0.09 +/- 0.01 mg/ml; p = 0.001) in rats with a portacaval shunt. The serum concentration of ammonia is correlated with albumin levels (r = 0.624; p = 0.04) and TAX correlates with liver weight (r = 0.729; p = 0.017) and albumin levels (r = 0.79; p = 0.007)

CONCLUSION

These findings suggest that in rats with a portacaval shunt a systemic reduction of oxidant scavenging ability, correlated with hyperammonemia, is principally produced. It could be hypothesized, therefore, that the reduced antioxidant defences would mediate a systemic inflammation.

摘要

背景

大鼠门腔分流会导致肝脏抗氧化清除能力下降。由于肝脏氧化/抗氧化稳态的这种失衡可能与氧化应激/抗氧化状态的全身变化同时存在,因此测定了门腔分流大鼠血浆中的氧化剂和抗氧化剂氧化还原状态。

结果

使用雄性Wistar大鼠:对照组(n = 11)和门腔分流组(PCS;n = 11)。测量了氧化剂血清晚期氧化蛋白产物(AOPP)、脂质氢过氧化物(LOOH)、抗氧化剂总硫醇(GSH)和总抗氧化状态(TAX)的血浆水平。术后4周还检测了白蛋白、氨、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、硫抑素和α-1-酸性糖蛋白(α1-AGP)。与对照大鼠相比,PCS组的AOPP显著更高(50.51±17.87对36.25±7.21微摩尔;p = 0.02),TAX显著更低(0.65±0.03对0.73±0.06毫摩尔;p = 0.007)。此外,门腔分流大鼠存在低白蛋白血症(2.54±0.08对2.89±0.18克/分升;p = 0.0001)和高氨血症(274.00±92.25对104.00±48.05微摩尔;p = 0.0001),硫抑素增加(0.23±0.04对0.09±0.01毫克/毫升;p = 0.001)。血清氨浓度与白蛋白水平相关(r = 0.624;p = 0.04),TAX与肝脏重量相关(r = 0.729;p = 0.017),与白蛋白水平相关(r = 0.79;p = 0.007)。

结论

这些发现表明,在门腔分流大鼠中,主要产生了与高氨血症相关的全身抗氧化清除能力下降。因此,可以假设抗氧化防御能力降低会介导全身炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/2262055/6bf0e1b69447/1476-5926-7-1-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/2262055/ed7c7e196f4d/1476-5926-7-1-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/2262055/6bf0e1b69447/1476-5926-7-1-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/2262055/ed7c7e196f4d/1476-5926-7-1-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cf0/2262055/6bf0e1b69447/1476-5926-7-1-2.jpg

相似文献

1
Plasma redox status is impaired in the portacaval shunted rat--the risk of the reduced antioxidant ability.门腔分流大鼠的血浆氧化还原状态受损——抗氧化能力降低的风险。
Comp Hepatol. 2008 Feb 5;7:1. doi: 10.1186/1476-5926-7-1.
2
Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat.大鼠肝功能不全诱导的高氨血症期间的肾氨和谷氨酰胺代谢
J Clin Invest. 1993 Dec;92(6):2834-40. doi: 10.1172/JCI116903.
3
Organ Distribution of N Following Intravenous Injection of [N]Ammonia into Portacaval-Shunted Rats.将[氮]氨静脉注射到门腔分流大鼠体内后氮的器官分布
Neurochem Res. 2017 Jun;42(6):1683-1696. doi: 10.1007/s11064-016-2096-5. Epub 2016 Nov 8.
4
Hyperammonemia and orotic aciduria in portacaval-shunted rats.门腔分流大鼠的高氨血症和乳清酸尿症
J Nutr. 1984 Jan;114(1):210-6. doi: 10.1093/jn/114.1.210.
5
The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.氨及门体分流对高氨血症性脑病时脑代谢、神经传递及颅内高压的影响
J Hepatol. 1997 Feb;26(2):387-95. doi: 10.1016/s0168-8278(97)80057-8.
6
Hepatic oxidant and antioxidant systems in portacaval-shunted rats.门腔分流大鼠的肝脏氧化和抗氧化系统
J Hepatol. 1992 Mar;14(2-3):253-8. doi: 10.1016/0168-8278(92)90167-n.
7
An attempt to decrease ammonia levels after portacaval anastomosis in dogs: hepatic periarterial neurectomy.犬门腔静脉吻合术后降低氨水平的尝试:肝动脉周围神经切除术。
Dig Dis Sci. 2002 Sep;47(9):1943-52. doi: 10.1023/a:1019635820789.
8
Portacaval shunt as an experimental model of impaired hepatic release of vitamin A in liver disease.门腔分流术作为肝病中肝脏维生素A释放受损的实验模型。
Gastroenterology. 1991 May;100(5 Pt 1):1379-84.
9
Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats.脾内肝细胞移植可纠正门腔分流大鼠的肝性脑病。
Hepatology. 1992 Jan;15(1):12-8. doi: 10.1002/hep.1840150104.
10
Local cerebral glucose metabolism in rats with chronic portacaval shunts.
J Cereb Blood Flow Metab. 1983 Sep;3(3):311-20. doi: 10.1038/jcbfm.1983.46.

引用本文的文献

1
Evaluation of serum lidocaine/monoethylglycylxylidide concentration to assess shunt closure in dogs with extrahepatic portosystemic shunts.评估血清利多卡因/单乙基甘氨酰二甲苯啶浓度以评估犬肝外门体分流的分流关闭情况。
J Vet Intern Med. 2021 Jan;35(1):261-268. doi: 10.1111/jvim.16030. Epub 2021 Jan 12.

本文引用的文献

1
Mitochondria, oxidative stress and cell death.线粒体、氧化应激与细胞死亡。
Apoptosis. 2007 May;12(5):913-22. doi: 10.1007/s10495-007-0756-2.
2
Current concepts on the pathophysiology of portal hypertension.门静脉高压病理生理学的当前概念。
Ann Hepatol. 2007 Jan-Mar;6(1):28-36.
3
Non-invasive diagnosis of cirrhosis and the natural history of its complications.肝硬化的无创诊断及其并发症的自然史
Best Pract Res Clin Gastroenterol. 2007;21(1):3-18. doi: 10.1016/j.bpg.2006.07.001.
4
Mechanisms of cell death in oxidative stress.氧化应激中的细胞死亡机制。
Antioxid Redox Signal. 2007 Jan;9(1):49-89. doi: 10.1089/ars.2007.9.49.
5
The inflammatory bases of hepatic encephalopathy.肝性脑病的炎症基础。
Eur J Gastroenterol Hepatol. 2006 Dec;18(12):1297-310. doi: 10.1097/01.meg.0000243873.94572.de.
6
Oxidative stress and metabolic diseases: Introduction.
Pathophysiology. 2006 Aug;13(3):127-8. doi: 10.1016/j.pathophys.2006.05.001. Epub 2006 Jun 16.
7
Oxidative stress in Alzheimer's disease.阿尔茨海默病中的氧化应激
Pathophysiology. 2006 Aug;13(3):195-208. doi: 10.1016/j.pathophys.2006.05.004. Epub 2006 Jun 15.
8
The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP).氧化型人血清白蛋白(晚期氧化蛋白产物,AOPP)的结构和药代动力学特性。
Drug Metab Pharmacokinet. 2006 Apr;21(2):140-6. doi: 10.2133/dmpk.21.140.
9
The acute-phase response of the liver in relation to thyroid hormone-induced redox signaling.
Free Radic Biol Med. 2006 May 1;40(9):1628-35. doi: 10.1016/j.freeradbiomed.2005.12.033. Epub 2006 Jan 25.
10
Oxidative stress and inflammation in pregnancy.孕期的氧化应激与炎症
Scand J Clin Lab Invest. 2006;66(2):121-7. doi: 10.1080/00365510500375230.